Literature DB >> 9555090

Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats.

A Kask1, L Rägo, J Harro.   

Abstract

Neuropeptide Y (NPY, 1 and 10 pmol), NPY Y1 receptor agonist [Leu31, Pro34]NPY (10 pmol) and Y2 agonist NPY13-36 (100 pmol) were administered unilaterally into the region of the nucleus locus coeruleus (LC) in rats. NPY (10 pmol) and NPY13-36 increased the percentage of open arm entries, the percentage of time spent on open part, number of both open and closed arm entries and line crossings in the open part while [Leu31,Pro34]NPY failed to modify elevated plus-maze behavior. These data suggest that NPY applied close to LC has anxiolytic-like effects by acting on NPY Y2, not on Y1 receptors. Thus, NPY Y2 receptors in the vicinity of LC may be involved in the regulation of anxiety in rats. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555090     DOI: 10.1016/s0006-8993(98)00076-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

Review 1.  Crossing the Worm-Brain Barrier by Using Caenorhabditis elegans to Explore Fundamentals of Human Psychiatric Illness.

Authors:  Donard S Dwyer
Journal:  Mol Neuropsychiatry       Date:  2018-01-11

2.  In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.

Authors:  James R Shoblock; Natalie Welty; Diane Nepomuceno; Brian Lord; Leah Aluisio; Ian Fraser; S Timothy Motley; Steve W Sutton; Kirsten Morton; Ruggero Galici; John R Atack; Lisa Dvorak; Devin M Swanson; Nicholas I Carruthers; Curt Dvorak; Timothy W Lovenberg; Pascal Bonaventure
Journal:  Psychopharmacology (Berl)       Date:  2009-12-02       Impact factor: 4.530

3.  The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.

Authors:  Rose-Marie Karlsson; Jessica S Choe; Heather A Cameron; Annika Thorsell; Jacqueline N Crawley; Andrew Holmes; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2007-09-22       Impact factor: 4.530

4.  Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice.

Authors:  Ngoc Khoi Nguyen; Simone B Sartori; Herbert Herzog; Ramon Tasan; Günther Sperk; Nicolas Singewald
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

5.  Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala.

Authors:  Amanda B Rostkowski; Tara L Teppen; Daniel A Peterson; Janice H Urban
Journal:  J Comp Neurol       Date:  2009-11-10       Impact factor: 3.215

Review 6.  Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors.

Authors:  Nicholas W Gilpin
Journal:  Alcohol       Date:  2012-05-04       Impact factor: 2.405

7.  Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.

Authors:  Ryan R Wyrofsky; Beverly A S Reyes; Daohai Yu; Lynn G Kirby; Elisabeth J Van Bockstaele
Journal:  Eur J Neurosci       Date:  2018-09       Impact factor: 3.386

8.  Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy.

Authors:  Jennifer C Wong; Lindsey Shapiro; Jacquelyn T Thelin; Elizabeth C Heaton; Rokon U Zaman; Martin J D'Souza; Kevin S Murnane; Andrew Escayg
Journal:  Neurobiol Dis       Date:  2020-10-25       Impact factor: 5.996

9.  The psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment.

Authors:  Dennis S Charney
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

Review 10.  Neuropeptide Y: A stressful review.

Authors:  Florian Reichmann; Peter Holzer
Journal:  Neuropeptides       Date:  2015-09-30       Impact factor: 3.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.